KIMBERLY RANDOLPH: Open Payments
NPI 1457788671 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,195 in 86 payments from 14 companies in 2025. Trend: 2023 $2,254 · 2024 $5,154 · 2025 $2,195
Food & beverage: $2,184Education: $11
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 32 | $833 |
| Novo Nordisk Inc | 15 | $395 |
| ViiV Healthcare Company | 10 | $279 |
| Corcept Therapeutics | 10 | $239 |
| ABBVIE INC. | 3 | $72 |
| Medline Industries LP | 1 | $71 |
| Lilly USA, LLC | 3 | $66 |
| PFIZER INC. | 3 | $56 |
| Amgen Inc. | 3 | $52 |
| Currax Pharmaceuticals LLC | 2 | $35 |
Products named: Biktarvy, Wegovy, Korlym, APRETUDE, Yeztugo, MAVYRET, Rybelsus, Ozempic.
Industry payments across FL — which companies pay providers there.
